Biotech Analyst Devarakonda, along with Monte Rosa Therapeutics, discuss harnessing AI to develop novel molecular glue degraders on an Analyst/Industry conference call to be held on April 23 at 2 pm.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GLUE:
- 5 Stocks that Analysts Love in March 2024
- Monte Rosa Therapeutics Unveils Corporate Strategy Presentation
- Monte Rosa Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
- Monte Rosa Therapeutics announces anticipated upcoming milestones
- Monte Rosa Therapeutics expects cash to fund operations into 1H26
